Clinical Trial Update: An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate [Phase 4]

View source ↗

Summary

Phase 4 study comparing tofacitinib with or without methotrexate to adalimumab with methotrexate in rheumatoid arthritis; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• METHOTREXATE (METHOTREXATE)
• XELJANZ (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Rhematoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2018-06-27